Form 4: LifeStance Health Group Officer Ujjwal Ramtekkar Reports Tax Withholding Share Transaction

Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, reports a transaction involving the withholding of shares to cover tax obligations upon the vesting of Restricted Stock Units (RSUs).

Summary

• On March 10, 2025, Ujjwal Ramtekkar, the Chief Medical Officer of LifeStance Health Group, had 4,346 shares of common stock withheld by the issuer to satisfy tax obligations related to the vesting of RSUs.
• The price per share for the tax withholding was $7.11.
• Following the transaction, Ramtekkar directly owns 129,435 shares of LifeStance Health Group common stock.
• This transaction was not an open-market sale but a reduction of shares issued upon settlement of vested RSUs.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a standard tax withholding transaction, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, specifically the withholding of shares to cover tax obligations upon the vesting of RSUs. It is a common practice among publicly traded companies to compensate employees with stock options and RSUs, which are then subject to tax withholding upon vesting.

Key Dates

Keywords

LifeStance Health Group, LFST, Ujjwal Ramtekkar, Chief Medical Officer, Form 4, SEC Filing, RSUs, Tax Withholding, Beneficial Ownership, Insider Transaction